CA2058194A1 - Immobilized d-amino acid oxidase and its use for the preparation of medicaments - Google Patents

Immobilized d-amino acid oxidase and its use for the preparation of medicaments

Info

Publication number
CA2058194A1
CA2058194A1 CA002058194A CA2058194A CA2058194A1 CA 2058194 A1 CA2058194 A1 CA 2058194A1 CA 002058194 A CA002058194 A CA 002058194A CA 2058194 A CA2058194 A CA 2058194A CA 2058194 A1 CA2058194 A1 CA 2058194A1
Authority
CA
Canada
Prior art keywords
units
amino acid
support material
acid oxidase
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002058194A
Other languages
French (fr)
Inventor
Klaus Sauber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2058194A1 publication Critical patent/CA2058194A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/18Multi-enzyme systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12N9/0024D-Amino acid oxidase (1.4.3.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/06Cephalosporin C; Derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

HOE 90/F 385 Immobilized D-amino acid oxidase and its use for the preparation of medicaments The invention relates to an enzyme-coated support material comprising D-amino acid oxidase and a support material. The support is a crosslinked copolymer, which comprises vinyl acetate units and/or vinyl alcohol units and units of a crosslinking agent. The D-amino acid oxidase-coated support can also be coated with catalase. The support material according to the invention can be used for the preparation of medicaments.

Description

20~819~
HOECHST AKTIENGESELLSCHAFT HOE 90/F 385 Dr.FI/sch Description Immobilized D-amino acid oxidase and its use for the preparation of medicaments D-amino acid oxidase (hereinafter DAO) catalyzes the oxidative deamination of D-amino acids to the correspond-ing ~-keto acids, ammonia and hydrogen peroxide.

In addition to the commercially available D~O from hog lQ kidneys, the enzyme is synthesized by bacteria, yeasts and molds. Trigonopsis variabilis stands out among these as the most potent DAO producer. In addition to the use of this enzyme for the separa~ion of racemates of D,L-amino acids and the quantitative determination of D-amino acids in various solution~, its ability to oxidatively deaminate cephalosporin C is particularly noteworthy. This catalytic property is used for the preparation of ~-ketoadipyl-7-aminocephalosporanic acid and glutaryl-7-aminocephalosporanic acid, which can be subsequently converted to 7-aminocephalosporanic acid by means of an acylase.

German Offenlegungsschrift 22 19 454 (US Patent 3 801 458) describes the conversion of cephaloæporin C
derivatives by means of activated cells of Trigonopsis variabilis CBS 40 95. "Activated~ here signifies that the yeast cells have been subjected to a phyRical and/or chemical process, so that the DAO in the cells is made available for catalyzing the oxidation of cephalosporin C, but is not liberated to a great extent.

The patent application WO 86 04 087 describes the purification and immobilization of DAO from Trigonopsis variabilis and the use of DAO for the oxidative deamin-ation of cephalosporin C. However, no detail are given about the operational stability, and the immobilization
2~81~

yield is given as 40%.

It was the object of the present invention to impro~e the stability of D-amino acid oxidase. Surprisingly, it has now been found ~hat coupling D-amino acid oxidase to a support material made of a crosslinked copolymer, substantially comprising vinyl acetate units and/or vinyl alcohol uni~s and units of a crosslinking agent, forms a complex in which the enzyme DAO retains its activity for a long period.

The invention thus relates to an enæyme-coated support materiall comprising D-amino acid oxidase and a porous bead-shaped support material, where the support material is a crosslinked copolymer, substantially comprising vinyl acetate units and/or vinyl alcohol units and units of a crosslinking agent, where the units of the crosslinking agent are copolymerized compounds of the formulae O (I) R1 - N j C - N - R2 A /

and/or iCH2 = C~- B
X 2 (II) where R1 and R2 in formula (I) can be identical or different and are vinyl, 1-acyloxyvinyl, allyl or 2-acyloxyallyl, A i5 a divalent hydrocarbon radical having 2 to 8 carbon atoms, B in formula (II) i8 a divalent hydrocarbon radical having 1 to 8 carbon atoms, and X is acyloxy, where the acyloxy group is a radical having 2 to 18 carbon atoms, the amount of crosslinking agent i6 1 to 60~ by weight, relative to the polymer, and the acyloxy groups of the vinyl acylate units are present as such, or some or all have been hydrolyzed to hydroxyl 20~8~94 groups, and the mean particle size of the beads is 2û to 800 ~m and the mean pore diameter is 2 to 10 000 nm.
It was surprising that the enzymes in an immobilized form following the coupling to the support mentioned show a storage stability of at least 6 months. In comparison with other known enzyme supports such as, for example, Eupergit (Rohm), vinyl-Sepharose (Kem-en-tec), BrCN-activated-Sepharose (Pharmacia), the support according to the invention showed a surprisingly high immobilization yield with DAO, and a longer operational stability. Particular preference is given to the use of the vinyl acetate-epoxy supports from Riedel de Haen, for example VA-Epoxy-~Biosynth.

The preparation of the porous, bead-shaped support materials used i6 disclosed in DE-A 33 44 912, to which reference is made here.

The coupling reaction between the enzyme~ used according to the invention and the support material is carried out in a known manner, such as is described for example in DE-A 24 07 340 or in the Gennan Patents 22 15 687, 24 21 789 and 25 S2 510.

The invention relates to the use of the support material according to the invention for the oxidative dçamination of cephalosporin C derivatives.

The term cephalosporin C derivatives means for example compounds such as those of the formula III
COOH
H2N-cH-(cH2)3coNHTf ~ (III) 0~ ~
COOH

in which X is an acetate group, a nucleophile radical, 20~81 9~

a heterocycle, a hydroxyl group or hydrogen r and salts thereof.

Cephalosporin C is a compound of the formula IV

R~H ~ ~ (IV~
d~ N_~ C~2 0 A c COOH
in which R is COOH
H2N - C - (CH2)3 ~ -~-Ketoadipyl-7-aminocephalosporanic acid i~ a compound of the formula Iv in which R i9 O O
HOOC - C - (CH2)3 - C -Glutary1-7-aminocephalosporanic acid i~ a compound of the formul~ IV in which R i8 O
HOOC - (Cll~)3 - C -7-Aminocephalosporanic acid i8 a compound of the formula IV in which R is hydrogen.

Furthermore the invention relates to a process for the preparation of the coated support materials, which comprises incubating a D-amino acid oxidase-containi.ng solution with a porous bead-shaped support material made of a crosslinked copolymer, substantially compri~ing vinyl acetate units and/or vinyl alcohol units and units of a crosslinking agent, where the units of the crosslinking agent are copolymerized compounds of the 2Q~81 94 .
formulae R1 - N j C j N - R2 (I) A
and/or [CH~ = C]- B
X 2 (II) where R1 and R2 in formula (I) can be identical or different and are vinyl, l-acyloxyvinyl, allyl or 2-acyloxyallyl, A i~ a divalent hydrocarbon radical having 2 to 8 carbon atoms, B in formula (II) is a divalent hydrocarbon group having 1 to 8 carbon atoms, and X is acyloxy, where the acyloxy group is a radical having 2 to 18 carbon atoms, the amount of crosslinking agent is 1 to 60% by weight, relative to the polymer, and the acyloxy groups of the vinyl acylate units are present as such, or some or all have been hydrolyzed to hydroxyl group~, and the mean particle size of the beads is 20 to 800 ~m and the mean pore diameter is 2 to 10 000 nm.

The vinyl acetate units of the support polymer preferably contain 2 to 18 carbon atoms, in particular 2 to 6 carbon atoms, in the acylate radical. Preferably, this is the acetate or propionate radical. Different acylate radicals can also be present in the polymer, i.e.
mixtures of the corresponding vinyl acylate~ can also be used for its preparation.

In the crosslinking agent according to the formula (I), A is preferably a branched or unbranched aliphatic hydrocarbon radical having 2 to S carbon atoms, in particular 2 or 3 carbon atoms. Particular preference iB
given to the ethylene or propylene radical. If Rl/R2 of this formula (I) is 1-acyloxyvinyl or 2-acyloxyallyl, then the acyloxy group therein preferably contains 2 to - 6 - 2~81~
18 carbon atoms, in particular 2 to 6 carbon atoms.
Preferably acyloxy i8 the acetate or propionate radical.
The R1/R2 radicals are preferably vinyl. A preferred crosslinker unit in the polymer used according to the invention is correspondingly derived from N,N~-divinylethyleneurea. This crosslinker produces a particularly hydrolysis-resistant coupling. Another preferred representative is N,N'-divinylpropyleneurea.

In the crosslinking agent according to the formula (II), -10 B is preferably a divalent hydrocarbon radical, in particular a branched ox unbranched alkylene radical having 2 to 6 carbon atoms, and preferably has the same meaning as described above for the radicals Rl and R2 in the formula (I). A preferred crosslinker of this type i8 for example 3,3-dimethylpentadiene 2,4-diacetate, which copolymerizes particularly easily with the vinyl acetate.

The amount of units of the crosslinking agent ~II) is generally 0 to 100%, in particular 0 to 60%, relative to the total amount of crosslinker units in the polymer.

The total amount of crosslinker units in the support polymer is within the ranges claimed and depends on the degree of crosslinking desired for the particular application. Thus for example in the application as a support material for enzyme reactions in an agitator vessel or for diagnostic agents a relatively low degree of crosslinking is advantageous, requiring a low content of crosslinking monomer units. Crosslinker contents below 0.1% by weight. lead in most cases to unusable products.
The lower limit can therefore be given as generally about 1% by weight. Crosslinker contents above 60% by weight are possible in principle, but do not as a rule give any further advantages.

According to the application the amount of crosslinker units is preferably 1 to 50~ by weight, and in particular 1 to 40~ by weight, relative to the polymer.

2 0 ~ 4 In the use according to the imJention as a support material for DAOI the lower lLmit is preferably 2.5~ by weigh~, and particularly preferably 10% by weight. If only crosslinker units according to formula (II) are present, their lower limit is preferably 2.5% by weight.

It can be advantageous if the support p~lymer additionally contains monomer units of a monomer copoly-merizable with vinyl acetate, where their amount generally does not exceed 10~ by weight, relative to the total polymer, and is preferably between 0.1 and 5% by weight. Examples ~f such monomers, which may be used as a mixture, are: N-vinylpyrrolidone, vinylene carbonate, (meth)acrylic acid, (meth)acrylonitrile, (meth)acryl-amide, alkyl (meth)acrylates each having 2 to 12 carbon atoms, preferably 2 to 4 carbon atoms, in the alkyl radical, hydroxyalkyl (meth)acrylates having 2 to 6 carbon atoms in the alkyl group, N-vinyl-N-alkylacetamide, styrene, ~-methylstyrene and the like.

The crosslinked support polymer is preferably in the form of beads, of predominan~ly spherical shape, which have a mean particle size in the dry, unswollen state of 20 to B00 ~m, preferably 50 to 300 ~m, and which preferably have a narrow particle size distribution. The optimum particle size in each case depends principally on the specific application. For a column procedure not carried out under pressure, for example, the particle size selected within the limits mentioned previously will be correspondingly larger than that for a process carried out under pressure. The beads of the polymer used according to the invention are predominantly macroporous.
The mean pore diameter is generally in the range from 2 to 10 000 nm, preferably 5 to 200 nm and in particslar 20 to 200 nm.

The acylate groups of the vinyl acetate unit& in the polymer used according to the invention are present as such or all or some have preferably been hydrolyzed ~o OH

- 8 - 2~819~
group~. At least 10~ by weight of the acyloxy groups are replaced by hydroxyl groups. However, the degree of hydrolysis is generally more ~han 50%, preferably more than 70% and in particular 90 to 100%. Crosslinked S polymers obtained by hydrolysis (polyvinyl alcohol~
preferably have at least some of the OH groups occupied by so-called spacer groups (with reference to spacers see below).

The copolymer in the form of a polyvinyl acetate gel is not hydrophilic; for use in water the ester group mu~t be hydrolyzed. This can be achieved in known manner by alkali, by swelling the product in an alcohol, e.g.
methanol, and adding aqueous alkali such as sodium hydroxide solution, or by transesterification of the alcohol-swollen product using cataly~ic amounts of acid or base and continuous removal, e.g. by distillation, of the ester formed (cf. German Patent 15 17 935). The hydrolysis can be terminated at any stage as required, so that the degree of hydrophilicity of the gel can be adjusted according to the application.

If the bead-shaped crosslinked polyvinyl alcohol gel is used as support for the DAO, which is to be attached to the support by a covalent bond, it is in many cases expedient previously to modify the gel with spacers.
Spacers are taken to mean compounds that react with the support polymer and also with the biologically active substance, and to a certain extent form a bridge between the two. The reaction of the bead polymer with the spacer can be accomplished directly or preferably after previous hydrolysis of the acylate groups. The degree of conversion depends inter alia on the bulkiness of the spacer and the accessibility of ~he acylate group and/or of the resulting secondary hydroxyl groups. Spacers which can be used are, according to the in~ention, homo- and heterobifunctional compounds known for this purpose, whose second functional group is responsible for the coupling to the biologically active substance to be 2~5~19~
g immobilized (cf. the German ~'atents 24 21 789 and 25 52 510, and also Ullmans Encyclopadie der technischen Chemie lUllmann's Encyclopedia of Industrial Chemistry], 4th Edition, Vol. 10, page 540 and ~Characterization of immobilized biocatalysts~, Verlag Chemie, Weinheim, 1979, p.53).

The spacers used are for example compounds which intro-duce the following groups:
-(CH2)n-NH2; n = 2-12 10(C~2)n-NH2; n = 1-8 ~ (CH2)n-CH ~ CH2;
n = 1-8 NH
- (CH2)n-CH --CH2;
O n = 1-8 ~(C~2jn-C\ ; X = H, OH, halogen X N3, OR

,~ 0~
15-(CH2)n~C ~ ; n = 1-6 OR R = alkyl radical having -CH2 ~ Y ; 1-6 carbon atoms ~ = NH2, N2, NCO

Preferred spacers are those that result in hydrolysis-resistant chemical compounds, such as epichlorohydrin or its homolog (~ epoxy-~-haloalkanes). The reaction with polyvinyl alcohols (polyvinyl acylates) is carried out in the absence or presence of a solvent, prefsrably in the presence of a catalyst. The length of reaction is 20~ 9~

depending on the temperature, which can be between room temperature and the reflux temperature of the epichlorohydrin (ll3-ll5~c) _ generally between 30 minutes and 24 hours. The cata]yst can be for example NaOH (in powder form) or aqueous alkalis, dimethylfoxmamide, triethylamine and other acid acceptors.

~he reaction between the DAO and the suppoxt material is carried out between 0 and ~40C, preferably at room temperature. The coupling reaction is preferably carried out at a fairly neutral pH, for example at a pH of from 5 to 9, preferably in the presence of phosphate buffers having an ionic strength of from 0.5 to 1.5 M.

D-amino acid oxidase can be isolated for example from hog kidneys, bacteria, yeasts or molds. Preference iB given to the use of the DAO from the yeast Trigonopsis variabilis CBS 4095. Coupling to the enzyme support can be performed with purified, partially purified or crude DAO-containing cell extracts. The purification of DAO can be performed by conventional procedures, e.g. by ammonium sulfate precipitation, or ion exchange or gel permeation chromatography. Preference is given to the use of DAO-containing enzyme solutions obtained by DEAE-cellulose ion-exchange chromatography.

Furthermore, catalase can also be coupled to the enzyme support by means of the DAO. The catalase can be isolated for example from animals, bacteria, yeasts or molds.
Preference is given to the use of the catalase from the yeast Trigonopsis variabilis CBS 4095. Coupling to the enzyme support can be performed with purified, partially purified or crude catalase-containing cell extracts. The catalase can be coupled to the enzyme support simulta-neously with the DAO, or before or af~er the DAO. Enzyme supports coated only with DAO or only with catala~e can also be mixed.

- 11- 205~94 using examples. Percentages given are by weight.

Example 1 The cultures of Trigonopsis variabilis CBS 4095 were grown first in shaken flasks and subsequently in stirred fermenters containing the medium described by Sentheshanmuganathan and Nickerson (J. Gen. Microbiol.
27, 465, 1962), and using either methionine or alanine as nitrogen source.

For DAO determination 0.4 g of cells is frozen, then thawed at acid pH, e.g. about pH 3-4; the freezing can be carried out at a temperature below -10C, e.g. about -20C. Freezing should be performed for a period sufficient to permeabilize the cells, e.g. at least 1 hour at -20C.

The activity is determined photometrically using the following assay system:

Solutions:

1) buffer 100 mM PPB; pH 7.3; air-saturated 2) o-phenylenediamine 0.02% in H2O
3) peroxidase 1 mg/ml in buffer
4) enzyme or permeabilized cells optimal: 0.5-1.0 units/ml
5) substrate 150 mM Na - CPC (100%) in buffer AssaY procedure:
= 405 nm (maximum) ~ = 4020 l/mol*cm v = 30C

2~5819~

Volume: Fin~l concentration:
1) 2.00 ml 83 mM
2) 0.50 ml 0.0034%
3) 0.10 ml 0.034 mg/ml 4) 0.05 ml wait 2 min 5) 0.30 ml 15.25 mM
2.95 ml Calculation:

10 Units = AE * dilution * total volume ml min * ~ * d * sample volume Under the conditions described above an enzyme activity in the fermenter of 200 U/l is achieved.

In the activity determinations using immobilized enzyme, samples are taken at intervals and the decrease in CPC
concentration is determined by HPLC. The mobile phase comprises 40 mM potassium phosphate buffer (pH 4.3) and 20% of MeOH with 10 mg/l of tetrabutylammonium hydrogen sulfate. The stationary phase is 6Lichrospher 100 RP 18 (5 ~m).

Example 2 Synthesis of the supports a) Suspension polymerization Under a nitrogen atmosphere in a 1.4 l gla~s flask having a stirrer, reflux condenser and thermometer an organic phase comprising a solution of 60.0 g of vinyl acetate, 40.0 g of N,N'-divinylethyleneurea, 80.0 g of 2-ethyl-hexanol, 20.0 g of Polyglykol B 11/50 (Hoechst AG) and 2.0 g of azoisobutyronitrile Porofor N (Bayer AG), was suspended with stirring in an aqueous phase comprising 3.2 g of Na2HPO4, 8.0 g of polyvinylpyrrolidone (molecular weight approximately 360 000) and 800 ml of water. The 20~8~94 _ 13 -polymerization was started by heating to 75C in a heating bath. After two hour0 the temperature was increased to 85C and after a further two hours the polymerization was completed. The suspension obtained wa~
cooled to 25~C, filtered off with suction and stirred for 30 minutes four times with l l of water each time, three times with 1 l of methanol each time and twice with 1 l of acetone each time, filtered off with suction and dried overnight at 50C and 200 mm Hg in a vacuum drying oven under nitrogen. The yield was 75 g. Cloudy beads with a glossy surface were obtained. The bulk density was 300 g/1. This gives a bulk volume of 3.3 ml/g.

b) Partial hydrolysis 50 g of dry product and 150 ml of methanol and a solution of 17.5 g of NaOH in 150 ml of water were stirred for 3 hours at 30C, filtered off with suction, neu~ralized in S00 ml of methanol with acetic acid, stirred once with 500 ml of methanol and twice each with 500 ml of acetone, filtered off with suction, sieved and dried. The yield was 34.4 g ~= 68.8% by weight) based on the polymer. The beads were cloudy and had a glossy surface. The bulk density was 353 g/l (calculated bulk volume 2.8 ml/g).
Sieving distribution: >300 ~m 19.0 g (55.2~ by weight), 200-300 ~m 8.9 g (25.9% by weight), 100-200 ~m 6.1 g ~17.9~ by weight) and 50-100 ~m 0.4 g ~1.2~ by ~eight).
Degree of hydrolysis (IR, molar basis): 73%.

c) Attachment of the spacer 10.0 g of the dry 50-200 ~m sie~e fraction were swollen for 4 hours in 100 ml of epichlorohydrin at 25C, then heated for 4 hours with gentle stirring to 115C, and, after cooling to 25C, filtered off with 6uction. Then the mixture was stirred twice with 200 ml of acetone each time for 30 minutes, filtered off with suction and kept overnight in a drying oven under reduced pressure at 50C
under nitrogen.
9.8 g of dry product was obtained having a bulk density of 315 g/l and an epoxide equivalent of 350 ~moltg.

- 14 _ 2058 ~ ~

Example 3 To 10 g of wet cells produced as in Example 1 having an activity of 30 U/g are added the 3ame weight of 20 mM
potassium phosphate buffer, pH 8.0, giving a 6uspension.
The mixture i8 ground in ~ cooled Dyno mill at a residence time of 3 x 5 min. The yield of activity in the supernatant after centrifugation at 13 000 g is 60 to 80%; on average that is 210 U. The slightly cloudy crude extract is dialyzed against a 20 mM potassium phosphate buffer, pH 8Ø Sufficient DEAE-cellulose from Whatman i~
then added to bind the DAO completely. The bound enzyme is subsequently poured into a column and the DAO is eluted with increasing ionic str~ngth (0-0.5 N NaCl). The active fractions are combined, concentrated by ultrafil-tration and rebuffered with 1 M potassium phosphatebuffer (pH = 8.0). On average, the DAO ~olution purified in this manner contains 25 U/ml.

Example 4 5 ml of a solution obtained according to Example 3 are added to 1 g of VA-Epoxy Biosynth~ from Riedel de Haen and allowed to stand in a sealed container for 3 days at room temperature. During this time the enzyme binds covalently to the oxirane group-containing support. The immobilized enzyme i8 then washed with 1 X NaCl solution. The mean binding efficiency i8 0.83. Small amounts are in the washing water. The immobilized enzyme contain~
approximately 32 U/g (wet we~ght, wwt). It is stored in a 20 mM potassium phosphate buffer, containing 0.02% of sodium azide, at 4 degrees Celsius.

Example 5 As Example 2, but the support used is Eupergit from Rohm, Darmstadt. Result in Table 1.

Example 6 2 ml of DAO solution are dialyzed against a 50 mM potas-sium phosphate buffer (pH=8.6). The buffered solution 20~8~ 9~
_ 15 -having a total of 60 U is incubated at room temperature (RT) for 18 h with 2 ml of vinyl-Sepharose suspension (60%) to effect immobilization. 1.2 ml of Sepharose containing 22 U/ml are obtained (see Table 1), corresponding to an immobilization yield of 43~. 10 U are present in the washing water, 80 that a value ~ of O.Sl is calculated.

Example 7 l ml of DAO solution containing 3.2 U, which had been dialyzed against 0.5 M potassium phosphate buffer, pH 8.7, are added to 0.2 g of CNBr-activated Sepharose (Pharmacia) at RT. After 90 min the coupling is completed, and the support is washed in accordance with the manufacturer's instructions. Excess binding groups are inactivated with glycine. Result see Table 1.

Example 8 The enzyme immobilized as in Example 4 is stored under th0 condition~ given in Example 4 and its activity was measured each month. In 6 months the activity does not decrease by more than 5%.

Example 9 Sodium cephalosporin C (40 mM) is dissolved at pH 7.3 in 20 mM potassium phosphate buffer, and the Eolution i6 thermostated to 30C with stirring and treated with oxygen. 2~ (w/w) of immobilized DAO are added to this and the mixture is maintained at the initial pH by means of an autotitrator. After completion of the reaction, the solution is drained off and the reactor is refilled. The enzyme remains in the vessel. The number of reactions i8 120. The reaction time is selected 80 that complete conversion is possible. This is 1 hour up to about 40 reactions, then 1.5 up to 90, and finally 2 h.

- 16 - ~0~819~
~able 1: Comparison of enzyme supports Binding efficiencyU/g td at 30 , ] twwt) pH=7.3 Eupergit 0.71 29 ~20 (Rohm) VA-Epoxy O.83 32 ~40 (Riedel de Haen) Vinyl-Sepharose 0.51 22 ~15 (Kem-en-tec) BrCN-activated Sepharose 0.7 6 ~6 (Pharmacia)

Claims (9)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An enzyme-coated support material comprising D-amino acid oxidase and a porous bead-shaped support material, where the support material is a crosslinked copolymer, substantially comprising vinyl acetate units and/or vinyl alcohol units and units of a crosslinking agent, where the units of the crosslinking agent are copolymerized compounds of the formulae (I) and/or (II) where R1 and R2 in formula (I) can be identical or different and are vinyl, 1-acyloxyvinyl, allyl or 2-acyloxyallyl, A is a divalent hydrocarbon radical having 2 to 8 carbon atoms, B in formula (II) is a divalent hydrocarbon radical having 1 to 8 carbon atoms, and X is acyloxy, where the acyloxy group is a radical having 2 to 18 carbon atoms, the amount of crosslinking agent is 1 to 60% by weight, relative to the polymer, and the acyloxy groups of the vinyl acylate units are present as such, or some or all have been hydrolyzed to hydroxyl groups, and the mean particle size of the beads is 20 to 800 µm and the mean pore diameter is 2 to 10 000 nm.
2. A support material as claimed in claim 1, wherein the D-amino acid oxidase originates from yeasts or molds.
3. A support material as claimed in claim 1 or 2, which contains D-amino acid oxidase and catalase.
4. A process for the preparation of a coated support material as claimed in claim 1 or 2, which comprises incubating a D-amino acid oxidase-containing solution with a porous bead-shaped support material made of a crosslinked copolymer, substantially comprising vinyl acetate units and/or vinyl alcohol units and units of a crosslinking agent, where the units of the crosslinking agent are copolymerized compounds of the formulae (I) and/or (II) where R1 and R2 in formula (I) can be identical or different and are vinyl, 1-acyloxyvinyl, allyl or 2-acyloxyallyl, A is a divalent hydrocarbon radical having 2 to 8 carbon atoms, B in formula (II) is a divalent hydrocarbon radical having 1 to 8 carbon atoms, and X is acyloxy, where the acyloxy group is a radical having 2 to 18 carbon atoms, the amount of crosslinking agent is 1 to 60% by weight, relative to the polymer, and the acyloxy groups of the vinyl acylate units are present as such, or some or all have been hydrolyzed to hydroxyl groups, and the mean particle size of the beads is 20 to 800 µm and the mean pore diameter is 2 to 10 000 nm.
5. The process as claimed in claim 4, wherein a D-amino acid oxidase-containing solution obtained from molds or yeasts is used.
6. The process as claimed in claim 4 or 5, wherein a D-amino acid oxidase-containing solution purified by ion exchange chromatography is used.
7. The process as claimed in one or more of claims 4 to 6, wherein D-amino acid oxidase- and catalase-contain-ing solutions are used.
8. The process as claimed in one or more of claims 3 to 7, wherein the incubation is performed at a temperature between 0°C and +40°C.
9. A process for the preparation of glutaryl-7-amino-cephalosporanic acid derivatives or .alpha.-ketoadipyl-7-aminocephalosporanic acid derivatives, wherein a coated support material as claimed in one or more of claims 1 to 3 and cephalosporin derivatives are used.
CA002058194A 1990-12-24 1991-12-20 Immobilized d-amino acid oxidase and its use for the preparation of medicaments Abandoned CA2058194A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4041755 1990-12-24
DEP4041755.7 1990-12-24

Publications (1)

Publication Number Publication Date
CA2058194A1 true CA2058194A1 (en) 1992-06-25

Family

ID=6421427

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002058194A Abandoned CA2058194A1 (en) 1990-12-24 1991-12-20 Immobilized d-amino acid oxidase and its use for the preparation of medicaments

Country Status (11)

Country Link
US (1) US5599702A (en)
EP (1) EP0492495A3 (en)
JP (1) JPH04365484A (en)
KR (1) KR920012449A (en)
AU (1) AU660438B2 (en)
CA (1) CA2058194A1 (en)
CZ (1) CZ284454B6 (en)
MX (1) MX9102792A (en)
NZ (1) NZ241116A (en)
TW (1) TW198064B (en)
ZA (1) ZA9110119B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342770A1 (en) * 1993-12-15 1995-07-06 Boehringer Mannheim Gmbh Carrier-fixed enzymes
US5980883A (en) * 1996-10-02 1999-11-09 Kuraray Co., Ltd. Polymer gel for medical use
KR20030076721A (en) * 1997-09-09 2003-09-26 바이오케미 게젤샤프트 엠베하 Esterase free enzymes
CN1531539A (en) 2001-04-19 2004-09-22 ��ŷ�����¶����ǹɷ����޹�˾ Enzymatic process for preparing cephalosporanic acid derivatives using 2-ketoacid derivatives
EP1754534A1 (en) * 2005-08-03 2007-02-21 MERCK PATENT GmbH Crosslinked hydrophile polymer
ES2528426T3 (en) * 2005-08-03 2015-02-09 Merck Patent Gmbh Crosslinked Hydrophilic Polymer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1385685A (en) * 1971-04-21 1975-02-26 Glaxo Lab Ltd Cephalosporin derivatives
DE2911192A1 (en) * 1979-03-22 1980-10-02 Boehringer Sohn Ingelheim INNOVATIVE IMMOBILIZED GLUCOSE OXIDASE CATALASE PREPARATION AND ITS USE FOR ENZYMATIC GLUCOSE OXIDATION
DE3404021A1 (en) * 1983-05-28 1984-11-29 Hoechst Ag, 6230 Frankfurt MACROPOROUS PEARL POLYMERISATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE3344912A1 (en) * 1983-12-13 1985-06-20 Hoechst Ag, 6230 Frankfurt CROSSLINKED POLYMERISATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
SE8500157D0 (en) * 1985-01-11 1985-01-11 Mosbach Klaus ISOLATION AND PARTIAL CHARACTERIZATION OF A D-AMINO ACID OXIDASE ACTIVE AGAINST CEPHALOSPORIN C FROM THE YEAST TRIGONOPSIS VARIABILIS
DE3629177A1 (en) * 1986-08-28 1988-03-17 Hoechst Ag CROSSLINKED POLYMERISATES AND METHOD FOR THE PRODUCTION THEREOF
DE3818851A1 (en) * 1988-06-03 1989-12-14 Hoechst Ag NEW TRANSAMINASE, THEIR MANUFACTURE AND ITS USE
DE4028119C1 (en) * 1990-09-05 1991-12-05 Hoechst Ag, 6230 Frankfurt, De
IT1252308B (en) * 1990-12-21 1995-06-08 Antibioticos Spa ENZYMATIC PROCEDURE FOR THE PRODUCTION OF 7- AMINOCEPHALOSPORANIC ACID AND DERIVATIVES

Also Published As

Publication number Publication date
TW198064B (en) 1993-01-11
MX9102792A (en) 1992-06-01
KR920012449A (en) 1992-07-27
ZA9110119B (en) 1992-09-30
EP0492495A3 (en) 1993-06-16
JPH04365484A (en) 1992-12-17
AU8989591A (en) 1992-06-25
US5599702A (en) 1997-02-04
CS399591A3 (en) 1992-11-18
NZ241116A (en) 1993-11-25
AU660438B2 (en) 1995-06-29
EP0492495A2 (en) 1992-07-01
CZ284454B6 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
US4266030A (en) Macroporous polymeric carrier for covalently binding proteins, its preparation and its use for fixing active proteins
US4247642A (en) Enzyme immobilization with pullulan gel
US4486549A (en) Process for preparing an amino group-containing polyacrylonitrile polymer
US4551482A (en) Macroporous, hydrophilic enzyme carrier
JPS61254190A (en) Immobilization of enzyme on carrier
CA1228196A (en) Oxirane resins for enzyme immobilization
US4906715A (en) N,N'-divinylalkylurea crosslinked polymers, a process for their preparation, and their use
US4542069A (en) Vinylene carbonate polymers, a process for their preparation and their use
US4170696A (en) Enzyme-immobilization carrier and preparation thereof
US5599702A (en) D-amino acid oxidase from Trigonopsis variabilis immobilized on porous copolymer beads
Bahulekar et al. Immobilization of penicillin G acylase on functionalized macroporous polymer beads
US4931476A (en) Crosslinked polymers and a process for their preparation
US4239854A (en) Enzyme-immobilization carriers and preparation thereof
JP2719047B2 (en) Carrier-immobilized penicillin G amidase, glutaryl-7-ACA acylase or D-amino acid oxidase
AU646285B2 (en) A process for the continuous conversion of cephalosporin derivatives into gluytaryl-7-aminocephalosporanic acid derivatives
US4767620A (en) Crosslinked polymers with carbonate ester groups, and a process for their preparation
US4764467A (en) Preparation of an insoluble biocatalyst
US4612288A (en) Oxirane resins for enzyme immobilization
CA1104110A (en) Enzyme-immobilization carriers and preparation thereof
Kálmán et al. A novel polyacrylamide-type support prepared by p-benzoquinone activation
Da Silva et al. Immobilization of α‐chymotrypsin onto hydrolyzed poly (ethylene)‐g‐co‐hydroxyethyl methacrylate
GB1597436A (en) Enzyme-immobilization carriers and preparation thereof
JP2660649B2 (en) Method for producing enzyme-immobilizing carrier
Luthra et al. Microgels as supports for α-chymotrypsin
JPS6019998B2 (en) Method for producing immobilized enzyme

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued